EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Digital image analysis allows objective stratification of patients with silent PIT1 ‐lineage pituitary neuroendocrine tumors

Jiangyan Zhao, Chenxing Ji, Haixia Cheng, Zhen Ye, Boyuan Yao, Ming Shen, Xuefei Shou, Xiang Zhou, Hongying Ye, Zhaoyun Zhang, Hong Chen, Yongfei Wang und 5 weitere

The Journal of Pathology: Clinical Research · 2023-11 · 9 (6) · 488-497

DOI: 10.1002/cjp2.340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology: Clinical Research, online erschienen am 04.09.2023. Verfasst von Jiangyan Zhao und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Huashan Hospital, Institutes of Biomedical Sciences, Fudan University, Shanghai, PR China. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Transcription Factor Pit-1, Neuroendocrine Tumors, Biomarkers, Tumor. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAMS Innovation Fund for Medical Sciences, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Studies describing the clinical presentation and prognosis of patients with silent PIT1 (pituitary specific transcription factor)‐lineage pituitary neuroendocrine tumors (PitNETs) are rare. We identified patients with positive PIT1 tumor staining but without evidence of hormone hypersecretion at a tertiary center. Clusters were obtained according to cell morphology and immunostaining from each patient's digitally segmented whole slide image. We compared the clinical presentations, radiological features, and prognoses of the different clusters. We identified 146 patients (68 male, 42.9 ± 14.1 years old) with silent PIT1‐lineage PitNETs. Morphology clustering suggested that tumors with large nuclei and apparent eccentricity were associated with a higher proportion of aggressiveness and a higher hazard of recurrence [hazard ratio (HR): 2.64, (95% CI, 1.06–6.55), p = 0.037]. Immunohistochemical clustering suggested that tumors with thyroid stimulating hormone (TSH) staining or all negative PIT1‐lineage hormones were associated with a higher proportion of aggressiveness and a higher risk of recurrence [HR: 12.4, (95% CI, 1.60–93.5), p = 0.015]. We obtained three‐tier risk profiles by combining morphological and immunohistochemical clustering. Patients with the high‐risk profile presented the highest recurrence rate compared with those in the medium‐risk and low‐risk profiles [HR: 3.54, (95% CI, 1.40–8.93), p = 0.002]. In conclusion, digital image analysis based on cell morphology and immunohistochemical staining allows objective stratification of patients with silent PIT1‐lineage tumors. Typical morphological characteristics of high‐risk tumors are large tumor nuclei and high eccentricity, and typical immunostaining characteristics are TSH staining or negative staining for all PIT1‐lineage hormones.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pituitary NeoplasmsTranscription Factor Pit-1Neuroendocrine TumorsBiomarkers, TumorImage Interpretation, Computer-AssistedHumansMaleAdultFemaleMiddle AgedImmunohistochemistryYoung AdultAgedCell LineagePrognosisRetrospective StudiesNeoplasm Recurrence, Local

Stichwörter der Autor:innen

artificial intelligenceclusteringnonfunctioningpituitary adenoma

Substanzen

Transcription Factor Pit-1Biomarkers, TumorPOU1F1 protein, human

Autor:innen und Institutionen

  • Department of Neurosurgery, Huashan Hospital, Institutes of Biomedical Sciences, Fudan University, Shanghai, PR China.
  • National Center for Neurological Disorders, Shanghai, PR China.
  • Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, PR China.
  • Neurosurgical Institute of Fudan University, Shanghai, PR China.
  • Shanghai Clinical Medical Center of Neurosurgery, Shanghai, PR China.
  • Department of Pathology, Huashan Hospital, Shanghai, PR China.

ORCID-Profile: Nidan Qiao

Förderung

  • CAMS Innovation Fund for Medical Sciences
  • National Natural Science Foundation of China

Zitieren

APA

Zhao, J., Ji, C., Cheng, H., Ye, Z., Yao, B., Shen, M., Shou, X., Zhou, X., Ye, H., Zhang, Z., Chen, H., Wang, Y., He, F., Zhao, Y., Gong, W., Zhang, Q., & Qiao, N. (2023). Digital image analysis allows objective stratification of patients with silent PIT1 ‐lineage pituitary neuroendocrine tumors. The Journal of Pathology: Clinical Research, 9(6), 488-497. https://doi.org/10.1002/cjp2.340

Vancouver

Zhao J, Ji C, Cheng H, Ye Z, Yao B, Shen M, et al. Digital image analysis allows objective stratification of patients with silent PIT1 ‐lineage pituitary neuroendocrine tumors. The Journal of Pathology: Clinical Research. 2023;9(6):488-497. doi:10.1002/cjp2.340

BibTeX
@article{Zhao2023,
  author = {Zhao, Jiangyan and Ji, Chenxing and Cheng, Haixia and Ye, Zhen and Yao, Boyuan and Shen, Ming and Shou, Xuefei and Zhou, Xiang and Ye, Hongying and Zhang, Zhaoyun and Chen, Hong and Wang, Yongfei and He, Fuchu and Zhao, Yao and Gong, Wei and Zhang, Qilin and Qiao, Nidan},
  title = {Digital image analysis allows objective stratification of patients with silent PIT1 ‐lineage pituitary neuroendocrine tumors},
  journal = {The Journal of Pathology: Clinical Research},
  year = {2023},
  volume = {9},
  number = {6},
  pages = {488--497},
  doi = {10.1002/cjp2.340}
}
Kostenlos starten →